Alzheimer's Disease International (ADI)
News, blogs and stories from across the field of dementia, the work of Alzheimer’s Disease International and our members.
Lecanemab is the first therapy of its kind approved in the EU that could potentially slow the progression of Alzheimer’s disease. The use of lecanemab will now be considered by national payers, who will assess the treatment against further nationally determined criteria.
This comes as the Appeals board of the European Commission were unable to reach a verdict following the “no opinion” decision of the Standing Committee on Medicinal Products for Human Use and the European Commission. The matter will now be referred the European Commission for a final decision.
‘Integrating palliative care for older adults’ was written with ADI, The Worldwide Hospice Palliative Care Alliance (WHPCA), SANAD Hospice Lebanon and Hamad Medical Corporation (HMC).
In this exercept from the essay 'Providing optimal dementia support to Indigenous people in North America', from the World Alzheimer Report 2022, Jordan P Lewis (Aleut) and Kristen M Jacklin write about the need for culturally tailored dementia care in Indigenous communities in North America.
We asked some of our sponsors what inspires them to support World Alzheimer's Month as well as people living with dementia and their families.
ADI warmly welcomes the positive initial data reported today by Eisai and Biogen on the CLARITY AD global Phase 3 clinical trial of lecanemab.
In this press release, it is revealed that the World Alzheimer Report 2022 finds as many as 85 percent of people with dementia could be missing out on post-diagnosis care.
In this exercept from the essay 'The impact of caregiving in LGBTQ+ communities', from the World Alzheimer Report 2022, Julien Rougerie outlines the challenges of caregiving faced by the LGBTQ+ community.
In this exercept from the essay 'Living to the best of one's ability', from the World Alzheimer Report 2022, Keith Oliver shares how the support of others has helped him to navigate life since his diagnosis 11 years ago.
In this blog, Shamayne Leelawati shares how her caring journey for her father changed after COVID-19 and how it inspired her to change the narrative around post-diagnostic care.